Expression of active human sialyltransferase ST6GalNAcI in Escherichia coli

Microbial Cell Factories

Volumn 8, Issue , 2009, Pages 50-

  Skretas, Georgios ^a,b   Carroll, Sean ^a   DeFrees, Shawn ^c   Schwartz, Marc F ^c   Johnson, Karl F ^c   Georgiou, George ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c Neose Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CHAPERONIN; GLYCOPROTEIN; MUCIN; PROTEIN DNAJ; PROTEIN DNAK; S PHASE KINASE ASSOCIATED PROTEIN; SIALIC ACID; SIALYLTRANSFERASE;

ARTICLE; BACTERIAL METABOLISM; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENETIC ENGINEERING; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN EXPRESSION; SIALYLATION; WILD TYPE;

ANIMALS; CATTLE; ESCHERICHIA COLI; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; MOLECULAR CHAPERONES; MUCINS; RECOMBINANT FUSION PROTEINS; SIALYLTRANSFERASES;

ANIMALIA; BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI;

EID: 70449481369     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-8-50     Document Type: Article

References (25)

1. Walsh G, Jefferis R. Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 2006, 24(10):1241-1252. 10.1038/nbt1252, 17033665.
2. Varki A. Sialic acids in human health and disease. Trends Mol Med 2008, 14(8):351-360. 10.1016/j.molmed.2008.06.002, 2553044, 18606570.
3. Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, Torup L, Sager T, Erbayraktar Z, Gokmen N. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 2003, 100(11):6741-6746. 10.1073/pnas.1031753100, 164517, 12746497.
4. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Nephrol Dial Transplant 2001, 16(Suppl 3):3-13.
5. Elliott S, Lorenzini T, Asher S, Aoki K, Brankow D, Buck L, Busse L, Chang D, Fuller J, Grant J. Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 2003, 21(4):414-421. 10.1038/nbt799, 12612588.
6. Weijers CA, Franssen MC, Visser GM. Glycosyltransferase-catalyzed synthesis of bioactive oligosaccharides. Biotechnol Adv 2008, 26(5):436-456. 10.1016/j.biotechadv.2008.05.001, 18565714.
7. Wildt S, Gerngross TU. The humanization of N-glycosylation pathways in yeast. Nat Rev Microbiol 2005, 3(2):119-128. 10.1038/nrmicro1087, 15685223.
8. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie 2001, 83(8):727-737. 10.1016/S0300-9084(01)01301-3, 11530204.
9. Johnson KF, Bezila D, Ngo W, Hakes D. Vectors for recombinant protein expression in E. coli. PCT Patent application publication WO2005/067601 2005,
10. Datta AK, Chammas R, Paulson JC. Conserved cysteines in the sialyltransferase sialylmotifs form an essential disulfide bond. J Biol Chem 2001, 276(18):15200-15207. 10.1074/jbc.M010542200, 11278697.
11. Bessette PH, Aslund F, Beckwith J, Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci USA 1999, 96(24):13703-13708. 10.1073/pnas.96.24.13703, 24128, 10570136.
12. Faulkner MJ, Veeravalli K, Gon S, Georgiou G, Beckwith J. Functional plasticity of a peroxidase allows evolution of diverse disulfide-reducing pathways. Proc Natl Acad Sci USA 2008, 105(18):6735-6740. 10.1073/pnas.0801986105, 2373332, 18456836.
13. de Marco A, Deuerling E, Mogk A, Tomoyasu T, Bukau B. Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol 2007, 7:32. 10.1186/1472-6750-7-32, 1904446, 17565681.
14. Kapust RB, Waugh DS. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 1999, 8(8):1668-1674. 10.1110/ps.8.8.1668, 2144417, 10452611.
15. Kolaj O, Spada S, Robin S, Wall JG. Use of folding modulators to improve heterologous protein production in Escherichia coli. Microb Cell Fact 2009, 8:9. 10.1186/1475-2859-8-9, 2642769, 19173718.
16. Hayhurst A, Harris WJ. Escherichia coli skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments. Protein Expr Purif 1999, 15(3):336-343. 10.1006/prep.1999.1035, 10092493.
17. Levy R, Weiss R, Chen G, Iverson BL, Georgiou G. Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones. Protein Expr Purif 2001, 23(2):338-347. 10.1006/prep.2001.1520, 11676610.
18. Walton TA, Sousa MC. Crystal structure of Skp, a prefoldin-like chaperone that protects soluble and membrane proteins from aggregation. Mol Cell 2004, 15(3):367-374. 10.1016/j.molcel.2004.07.023, 15304217.
19. Sklar JG, Wu T, Kahne D, Silhavy TJ. Defining the roles of the periplasmic chaperones SurA, Skp, and DegP in Escherichia coli. Genes Dev 2007, 21(19):2473-2484. 10.1101/gad.1581007, 1993877, 17908933.
20. Jarchow S, Luck C, Gorg A, Skerra A. Identification of potential substrate proteins for the periplasmic Escherichia coli chaperone Skp. Proteomics 2008, 8(23-24):4987-4994. 10.1002/pmic.200800288, 19003857.
21. Yamamoto Y, Ritz D, Planson AG, Jonsson TJ, Faulkner MJ, Boyd D, Beckwith J, Poole LB. Mutant AhpC peroxiredoxins suppress thiol-disulfide redox deficiencies and acquire deglutathionylating activity. Mol Cell 2008, 29(1):36-45. 10.1016/j.molcel.2007.11.029, 2239235, 18206967.
22. Kumar JK, Tabor S, Richardson CC. Proteomic analysis of thioredoxin-targeted proteins in Escherichia coli. Proc Natl Acad Sci U S A 2004, 101(11):3759-3764. 10.1073/pnas.0308701101, 374317, 15004283.
23. Santini CL, Bernadac A, Zhang M, Chanal A, Ize B, Blanco C, Wu LF. Translocation of jellyfish green fluorescent protein via the Tat system of Escherichia coli and change of its periplasmic localization in response to osmotic up-shock. J Biol Chem 2001, 276(11):8159-8164. 10.1074/jbc.C000833200, 11099493.
24. Skretas G, Georgiou G. Genetic analysis of G protein-coupled receptor expression in Escherichia coli: inhibitory role of DnaJ on the membrane integration of the human central cannabinoid receptor. Biotechnol Bioeng 2009, 102(2):357-367. 10.1002/bit.22097, 2666920, 18828176.
25. DeFrees S, Wang ZG, Xing R, Scott AE, Wang J, Zopf D, Gouty DL, Sjoberg ER, Panneerselvam K, Brinkman-Van der Linden EC. GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli. Glycobiology 2006, 16(9):833-843. 10.1093/glycob/cwl004, 16717104.